Babesia gibsoni P50 antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Babesia gibsoni P50 antibodies pairs and antigen for animal health (animal Dog/Canine, Bovines/Cattle, Equine/Horse infectious disease babesiosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Multiple species disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P262-Tg001-Ag01	Recombinant Babesia gibsoni P50 protein	$3090.00
GMP-VT-P262-Tg001-Ab01	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P262-Tg001-Ab02	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P262-Tg001-Ab03	Anti-Babesia gibsoni P50 human monoclonal antibody (mAb)	$3090.00
GMP-VT-P262-Tg001-Ab04	Anti-Babesia gibsoni P50 human monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P262-Tg001-Ag01
Product Name	Recombinant Babesia gibsoni P50 protein
Pathogen	Babesia gibsoni
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Babesia gibsoni P50 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Babesia gibsoni level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse infectious disease with babesiosis.
Tag	His
Product description	Recombinant Babesia gibsoni P50 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P262-Tg001-Ab01,GMP-VT-P262-Tg001-Ab02
Pathogen	Babesia gibsoni
Product Name	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Babesia gibsoni P50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Babesia gibsoni antibodies in Babesia gibsoni level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse infectious disease with babesiosis.
Product description	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Babesia gibsoni antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P262-Tg001-Ab03,GMP-VT-P262-Tg001-Ab04
Pathogen	Babesia gibsoni
Product Name	Anti-Babesia gibsoni P50 human monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Recombinant Babesia gibsoni P50 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Babesia gibsoni antibodies in Babesia gibsoni level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse infectious disease with babesiosis.
Product description	Anti-Babesia gibsoni P50 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from sterile PBS, PH 7.4
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen Information

Babesia gibsoni: A Comprehensive Scientific Exploration

1. Pathogen Nomenclature and Description:

Scientific Name and Classification:

Babesia gibsoni, a protozoan parasite, has garnered attention within the scientific community due to its pathogenicity. The name "Babesia" is derived from Victor Babes, a Romanian bacteriologist who made significant contributions to the field of parasitology. This pathogen is part of the genus Babesia, which is primarily composed of parasitic organisms that infect the red blood cells of their hosts. Babesia gibsoni is a eukaryotic microorganism, signifying its complex cellular structure with a distinct nucleus, in contrast to prokaryotic bacteria and viruses.

2. Pathogen Structural Features:

Babesia gibsoni possesses a genome rich in genes essential for its survival, reproduction, and evasion of the host immune system. Its genetic makeup includes genes that encode for proteins crucial to its parasitic lifestyle. Among these proteins, several are responsible for the invasion of host erythrocytes and the establishment of an intracellular niche for replication.

3. Host Range and Associated Pathologies:

Susceptible Hosts:

Babesia gibsoni primarily infects canids, making it particularly significant in veterinary medicine. Domestic dogs and wild canids are susceptible hosts for this parasite. Within these host populations, some individuals may develop clinical infections, while others may carry the parasite without displaying apparent symptoms.

Diseases Induced:

Infection with Babesia gibsoni results in a condition known as canine babesiosis. The disease exhibits various clinical manifestations, including pyrexia (fever), hemolytic anemia, icterus (jaundice), and lethargy in infected dogs. In severe cases, babesiosis can be life-threatening, posing a substantial mortality risk, especially in puppies and immunocompromised individuals.

4. Life Cycle:

The life cycle of Babesia gibsoni is intricately tied to its transmission and pathogenesis. It involves several stages:

A. Transmission:

Vector-Borne Transmission: Unlike many other protozoan parasites, Babesia gibsoni is primarily transmitted via the bite of a competent vector. In the case of this pathogen, the primary vector is the brown dog tick, Rhipicephalus sanguineus. When an infected tick bites a susceptible canine host, it may transmit the pathogen, initiating the infection.

B. Infection and Multiplication:

Invasion of Erythrocytes: Once inside the host, the parasite invades red blood cells, where it can multiply and undergo asexual replication. This intracellular location allows the pathogen to evade the host immune system and persist within the host for an extended period.

C. Transmission Back to the Vector:

Tick Acquisition of the Infection: When another tick feeds on the infected host, it ingests Babesia gibsoni along with the host's blood.

D. Reproduction in the Vector:

Sexual Reproduction: Within the tick vector, the parasite undergoes sexual reproduction, leading to the development of sporozoites in the tick's salivary glands.

E. Transmission to New Hosts:

Saliva-Based Transmission: When the infected tick bites a new host, it injects sporozoites along with its saliva, thus completing the transmission cycle.

5. Diagnostic Approaches:

Accurate diagnosis of Babesia gibsoni infection is crucial for the timely management of affected dogs and the prevention of disease spread. Several diagnostic modalities are available, including:

A. Microscopic Examination:

Blood smears are stained and examined under a microscope to visualize the parasite within red blood cells. This method provides a definitive diagnosis when the organism is observed.

B. Serological Assays:

Enzyme-linked immunosorbent assays (ELISA) and indirect fluorescent antibody tests (IFAT) are commonly used to detect antibodies against Babesia gibsoni. These assays are particularly useful for identifying past exposure to the pathogen.

C. Molecular Techniques:

Polymerase chain reaction (PCR) assays target specific gene sequences within the Babesia gibsoni genome. Prominent targets include the 18S ribosomal RNA gene and heat shock protein genes. PCR is highly sensitive and can detect low-level infections, making it a valuable tool for diagnosis.

In summary, Babesia gibsoni is a protozoan parasite of significant veterinary importance, causing canine babesiosis. Its complex life cycle, involving ticks as vectors, highlights the need for robust diagnostic methods to identify infected dogs and implement appropriate treatments. Further research on the pathogen's genetics and virulence factors is ongoing, offering the potential for improved control strategies and therapeutic interventions in the future. Understanding the detailed aspects of Babesia gibsoni's biology is crucial for the effective management of this pathogen in canine populations, ensuring the health and well-being of our four-legged companions.

About GDU